Peptides DB
Research-centric peptide and protocol reference hub
Study 12 of 47NAD+ (Nicotinamide Adenine Dinucleotide) literatureeuropepmc2026

Thermodynamic metabolic modeling of growth and bioproduction potential of the acetogen Acetobacterium woodii with and without redox cofactor swaps.

The study suggests that redox cofactor swaps could theoretically enhance growth rates in Acetobacterium woodii, but practical applications and outcomes remain to be validated.

Read at europepmcAdd to compare

Where it sits

this study against the rest of the nad+ (nicotinamide adenine dinucleotide) corpus
17
Preclinical · this one
23
Observational
1
Open-label
1
Randomised
5
Reviews

Summary and findings

This study investigates the metabolic modeling of the acetogen Acetobacterium woodii, focusing on the effects of redox cofactor swaps on growth and bioproduction. The analysis suggests that theoretical cofactor swaps could increase growth rates by a factor of 5 under specific conditions, with a more realistic increase of up to 2.5-fold achievable under broader concentration ranges. No therapeutic claims are made.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Up to 2.5-fold increase in growth rate under broader concentration ranges.2026

Abstract

The authors’ words, as europepmc supplied them

Acetogenic bacteria such as Acetobacterium woodii use the Wood-Ljungdahl pathway to convert H2/CO2 and other C1 substrates into acetate and couple it via chemiosmotic energy conservation with ATP synthesis. To coordinate the associated electron flows under tight thermodynamic constraints, acetogens use not only NAD(H) and NAD(P)H but also ferredoxin as a third major redox cofactor. In this work, we systematically explore how cofactor specificity in redox reactions, including potential cofactor swaps, may influence growth and bioproduction. We initially reconstructed and validated a large-scale constraint-based metabolic model of A. woodii equipped with standard Gibbs-free-energy values and metabolite concentration bounds. We then analyzed the effects of swapping redox cofactors in the model. This analysis revealed that, in theory, suitable cofactor swaps could increase the growth rate by a factor of 5 compared to the wild type, but only under very high H2 and CO2 concentrations and with tight ranges for the redox states of the cofactors. More realistic solutions with higher driving forces and broader concentration ranges would still enable an up to 2.5-fold increase in growth rate and are based on two key swaps: (a) replacement of the hydrogen-dependent CO2 reductase (HDCR) by a NADPH-dependent formate dehydrogenase and (b) substitution of NAD+ by NADP+ in the bifurcating hydrogenase. These variants, which were frequently favored by the algorithm in different scenarios and are used by other acetogens, increase the amount of reduced ferredoxin available for subsequent ATP generation. Unexpectedly, our analysis further revealed that the use of ferredoxin and NADH alone (in combination with suitable cofactor swaps) could lead to similar growth rates and driving forces as for the wild type. We discuss possible reasons why these solutions may not have been selected by evolution. In particular, we show that the native redox cofactor specificities of A. woodii facilitate near-maximal driving forces under a wide range of H2 and CO2 concentrations. Finally, we evaluated production of 15 native and heterologous chemicals from four C1-substrate regimes. This analysis reveals that targeted cofactor engineering can in many (but not all) cases (i) enable growth-coupled synthesis of a target chemical if it is infeasible in the native A. woodii strain or (ii) enhance the thermodynamic driving force of product synthesis. Overall, this work provides a valuable resource and a generalizable thermodynamics-based framework for evaluating redox engineering strategies in acetogens and other energy-limited microorganisms.

Elsewhere in the NAD+ (Nicotinamide Adenine Dinucleotide) corpus

CBioactive vitamin E-NAD<sup>+</sup> conjugate nanoparticles for osteoarthritis management via simultaneous suppression of inflammation and oxidative stress.Biomaterials · 2026 · Not reported in abstract.AnimalBNAD metabolism mediates a sex-specific protection against early life infectionsbiorxiv-preprint · 2026 · Higher birth NAD levels in females were associated with reduced infection burdens during the first 3 years of life.HumanBControl-referenced bacterial bioluminescence reveals a two-axis salivary response phenotype in benign and malignant breast disease.Talanta · 2026 · n=200 · Not reported in abstract.HumanBGenetic modulation of NAD(P)H homeostasis reveals distinct redox-coupled metabolic vulnerabilities.Nature metabolism · 2026 · Not reported in abstract.HumanDA context-dependent framework for targeting NAD metabolism in cancer.Cell metabolism · 2026reviewBPart 1 of a 2-part, open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 3 consecutive days of intramuscular and subcutaneous injectionsbiorxiv-preprint · 2026 · 9.97% average daily increase in NAD+ for 100 mg IM.Human